Navigation Links
3SBio Inc. to Hold Annual General Meeting
Date:8/20/2008

SHENYANG, China, Aug. 20 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the 2008 Annual General Meeting of Shareholders of 3SBio Inc. will be held on September 12, 2008 (Friday) at 10:00 a.m. (Beijing time) at No.3 A1, Road 10, Shenyang Economy & Technology Development Zone, Shenyang 110027, People's Republic of China.

Further information is available on the 3SBio Inc. website at http://www.3sbio.com under the heading "Investors", and additional information about 3SBio Inc. is available in its annual report on Form 20-F for the year ending December 31, 2007 filed with the U.S. Securities and Exchange Commission, which can be accessed at the following link: http://bbs.3sbio.com/en/News/ShowInfo_n16.aspx?ID=30 .

About 3SBio Inc.

3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China.

For more information, please visit 3SBio on the web at http://www.3sbio.com .

For further information, please contact:

Investor Contact:

Kevin Teo, CFO

3SBio Inc.

Tel: +86-24-2581-1820

Investor Relations (US):

Mahmoud Siddig

Taylor Rafferty

Tel: +1-212-889-4350

Investor Relations (HK):

Ruby Yim

Taylor Rafferty

Tel: +852-3196-3712

Media Contact:

Jason Marshall

<
'/>"/>
SOURCE 3SBio Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. 3SBio Inc. Announces Second Quarter 2008 Results
2. 3SBio Inc. Schedules 2008 Second Quarter Earnings Release On Tuesday, August 12, 2008
3. 3SBio Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
4. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
5. 3SBio Inc. to Present at The Oppenheimer 2nd Annual China Dragon Call Conference
6. 3SBio Inc. Announces First Quarter 2008 Results
7. 3SBio Inc. Schedules 2008 First Quarter Earnings Release on Wednesday, May 14, 2008
8. 3SBio Inc. Approves Share Repurchase Program
9. 3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
10. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
11. 3SBio Inc. Announces Change to the Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)... Through science fairs, workshops, kits for building ... 25 organizations will continue their work to increase awareness ... in daily life with the aid of SPIE ... 10 countries, are the first of two groups of ... the international society for optics and photonics , in ...
(Date:5/21/2013)... 2013 Savoury Systems International (SSI), a ... Braddy to Southeastern USA Sales Broker. Braddy’s new role ... in the Southeast. , In 2004 Braddy ... supplier to food processors and industrial manufacturers. Braddy ... food industry and has over 25 years of sales ...
(Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2
... , , SAN MARINO, Calif., ... scientist at biotechnology company Viral Genetics (Pink Sheets: VRAL), will ... Newell,s presentation entitled: "The Impact of Custom Peptides on Chronic ... The conference is being held at The Loews Santa Monica ...
... , DAEJEON, South Korea, Sept. 16 ... fully-human monoclonal antibodies for the treatment of cancer and inflammatory ... a Series A financing. OrbiMed,s Caduceus Asia Partners and ... from an international syndicate including Green Cross, Tong Yang and ...
... BEIJING, Sept. 16 /PRNewswire-Asia/ -- ... has announced it will broaden inclusion,criteria for its ... use,stem cells derived from peripheral blood to treat ... foot ulcers involves intensive,wound management, risk reduction and ...
Cached Biology Technology:Viral Genetics' Lead Scientist Dr. M. Karen Newell Will Present at 11th Annual SoCalBio Investor and Partnership Conference 2PharmAbcine Closes USD $6 Million Series A Financing 2PharmAbcine Closes USD $6 Million Series A Financing 3PharmAbcine Closes USD $6 Million Series A Financing 4Indian Stem Cell Trial to Broaden Diabetic Foot Inclusion Criteria 2Indian Stem Cell Trial to Broaden Diabetic Foot Inclusion Criteria 3Indian Stem Cell Trial to Broaden Diabetic Foot Inclusion Criteria 4
(Date:5/20/2013)... a compound abundant in the Mediterranean diet takes away ... altering a very specific step in gene regulation, this ... die as scheduled. , One way that cancer cells ... them to die on a regular cycle that is ... by Ohio State University researchers, found that a compound ...
(Date:5/20/2013)... Geology articles posted online ahead of ... wide swath of geoscience subdisciplines, including minerals exploration, ... Locations studied include Siberia; the Sumatran subduction margin; ... Ukraine; Mars; and the Southeastern U.S. Atlantic Margin. ... and plate tectonics;, 2. The clear fingerprint of ...
(Date:5/18/2013)... The AGA Research Foundation is honored to announce ... in Digestive Cancer, which will support Andrew D. Rhim, ... University of Pennsylvania, Philadelphia, as he furthers his research ... and cancer progression. , "The AGA Research Foundation is ... distinguished clinicians and AGA Legacy Society members," said Nicholas ...
Breaking Biology News(10 mins):The compound in the Mediterranean diet that makes cancer cells 'mortal' 2The compound in the Mediterranean diet that makes cancer cells 'mortal' 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 2New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 3New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 4New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 5New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 6New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 7New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 8New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 9New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 10New in GEOLOGY: Gems, Darwin, Mars, Hemp, Snowball Earth, a Siberian Impact Crater, and More 11AGA Research Foundation grant furthers digestive cancer research 2
... of bees and other pollinators is not, at this ... of an international study published in the latest edition ... , Co-author, CSIRO Entomology,s Dr Saul Cunningham, says ... for pollinators is still growing and some highly pollinator-dependant ...
... A team of researchers led by North Carolina State University ... devices and a host of other revolutionary medical implants. The ... material can be used to create new devices that can ... sensors for diabetics and artificial hemo-dialysis membranes that can scrub ...
... 156th Acoustical Society of America (ASA) meeting convenes next ... Spa in Miami. Reporters are invited to visit the ... On this site are posted news releases and ... 660 talks and posters. They relate to a cross-section ...
Cached Biology News:Pollinator decline not reducing crop yields just yet 2NC State finds new nanomaterial could be breakthrough for implantable medical devices 2The 156th Acoustical Society of America Meeting, Nov. 10-14, Miami, Fla. 2The 156th Acoustical Society of America Meeting, Nov. 10-14, Miami, Fla. 3The 156th Acoustical Society of America Meeting, Nov. 10-14, Miami, Fla. 4
Ready-to-use solution....
ready-to-use solution...
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Clone/PAD: ZMD.420. Immunogen: ... Specificity: Specific for the ... Reactivity: Human (positive control: ... Based on sequence homology reactivity ...
Biology Products: